These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2973777

  • 1. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency].
    Lellouche D, Delorme G, Merlet P, Dubois-Randé JL, Duval AM, Tarral A, Bourdarias JP, Vernant P.
    Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777
    [Abstract] [Full Text] [Related]

  • 2. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B, Bouchoucha H, Scholl JM, Hennetier G, Benacerraf A, Achard F, Bock F.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P, Garraffo R, Sbirrazzuoli V, Lapalus P, Morand P.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [Abstract] [Full Text] [Related]

  • 4. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M, Rochiccioli JP, Edouard P, Fourcade J, Massabuau P, Puel J, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [Abstract] [Full Text] [Related]

  • 5. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft].
    Dubois-Randé JL, Loisance D, Duval-Moulin AM, Deleuze P, Lellouche D, Tavolaro O, Hittinger L, Benvenuti C, Merlet P, Brun D.
    Arch Mal Coeur Vaiss; 1989 Sep; 82(8):1433-8. PubMed ID: 2529834
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF, Valdes AM, Reddy PS.
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [Abstract] [Full Text] [Related]

  • 9. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M, Levine TB, Cohn JN.
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery].
    George M, Atallah G, Lehot JJ, Bastien O, Durand PG, Estanove S.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():57-62. PubMed ID: 2147836
    [Abstract] [Full Text] [Related]

  • 11. Acute effects of enoximone in chronic heart failure.
    Saborowski F, Peters P, Schneider M, Fehske W, Dieterich HA.
    J Cardiovasc Pharmacol; 1989 Sep; 14 Suppl 1():S57-61. PubMed ID: 2480487
    [Abstract] [Full Text] [Related]

  • 12. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F, Peters P, Schneider M.
    Z Kardiol; 1991 Sep; 80 Suppl 4():63-7. PubMed ID: 1833900
    [Abstract] [Full Text] [Related]

  • 13. [Sulmazole: a new positive inotropic agent].
    Renard M, Jacobs P, Melot C, Dresse A, Bernard R.
    Ann Cardiol Angeiol (Paris); 1984 Sep; 33(4):219-22. PubMed ID: 6465815
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
    Coulaud JM, Faitg R, Poler F, Rezgui N, Besse B, Lissac J.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R.
    Z Kardiol; 1991 Sep; 80 Suppl 4():7-14. PubMed ID: 1833902
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
    Birnbaum DE, Preuner JG, Gieseke R, Kasper-König W, Trenk D, Jähnchen E, Dieterich HA.
    Z Kardiol; 1991 Sep; 80 Suppl 4():47-52. PubMed ID: 1833897
    [Abstract] [Full Text] [Related]

  • 18. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW.
    Z Kardiol; 1994 Sep; 83 Suppl 2():49-53. PubMed ID: 8091824
    [Abstract] [Full Text] [Related]

  • 19. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration.
    el Allaf D, D'Orio V, Cremers S, Carlier J.
    G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393
    [Abstract] [Full Text] [Related]

  • 20. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
    Orellano L, Darwisch M, Dieterich HA, Köllner V.
    Z Kardiol; 1991 Oct; 80 Suppl 4():53-7. PubMed ID: 1833898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.